• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

11例肾母细胞瘤患者的保肾手术

Nephron-sparing procedures in 11 patients with Wilms' tumor.

作者信息

Linni K, Urban C, Lackner H, Höllwarth M E

机构信息

Department of Pediatric Surgery, University of Graz, Auenbruggerplatz 34, 8036 Graz, Austria.

出版信息

Pediatr Surg Int. 2003 Aug;19(6):457-62. doi: 10.1007/s00383-003-0957-x. Epub 2003 May 17.

DOI:10.1007/s00383-003-0957-x
PMID:12756594
Abstract

PURPOSE

In unilateral Wilms' tumor (WT), tumor nephrectomy is the standard surgical approach, whereas partial nephrectomy (PN) is controversially discussed. The aim of our retrospective study was to show that in selected cases of unilateral WT kidney-sparing operations could be a reasonable alternative to nephrectomy and to discuss the results of patients with bilateral WT treated by tumor enucleation.

MATERIALS AND METHODS

From 1981 to 1998, seven patients with unilateral nephroblastoma (four stage I, one stage III and two stage IV) had tumor resection by PN (five right side, two left side), which was planned when the tumor volume was reduced after 4 to 6 weeks of chemotherapy by at least 50%, when the tumor occupied one pole or was easily resectable, when 50% or more of the kidney tissue remained and when paraaortic lymph nodes were free by intraoperative histological examination. In four patients with bilateral WT (stage V) bilateral tumor enucleation was carried out-except in one patient in whom the contralateral kidney had to been removed because of extension of the tumor via the inferior vena cava to the right atrium. All patients ( n = 11) received pre- and postoperative chemotherapy followed by radiotherapy in four patients.

RESULTS

All patients with unilateral WT ( n = 7) are still alive and disease free (follow-up time: mean 6.6 years, range: 28 months to 11 years) with normal renal function, although two patients with secondary nephrectomy revealed creatinine clearance levels at the lower range. In six patients primary PN was performed successfully. In a stage III tumor patient (intraperitoneal metastasis, free lymph nodes), secondary nephrectomy was necessary due to renal arterial thrombosis 2 days after PN. In one stage IV tumor patient (lung metastasis, free lymph nodes), the primary resection was not far enough away from the tumor margin so that an additional slice of tissue with then tumor-free margins had to be resected. This patient evolved a local relapse 19 months after PN and had to be nephrectomised thereafter. In the group of bilateral WT patients ( n = 4), one child died 2 months after surgery during chemotherapy because of central venous line sepsis. One patient who additionally suffered from inferior vena cava tumor thrombosis extending to the right atrium making nephrectomy of the right kidney necessary developed chronic renal failure 4.7 years postoperatively. The other two stage V tumor patients have creatinine clearance levels within the normal range.

CONCLUSIONS

Kidney-sparing procedures remain the operative approach of choice in patients with bilateral WT, but bear the risk of chronic renal failure when one kidney has to be removed. PN in children with unilateral WT, carried out by an experienced surgeon, is a reasonable alternative to nephrectomy if strict guidelines such as excellent tumor response to preoperative chemotherapy and easy resectability far away from the tumor margins through healthy kidney tissue are followed. Paraaortic lymph nodes must be free of tumor invasion in order to avoid local radiotherapy. PN prevents the patient from having to have dialysis in cases of contralateral nephrectomy resulting from metachronous WT or subsequent renal trauma.

摘要

目的

在单侧肾母细胞瘤(WT)中,肿瘤肾切除术是标准的手术方法,而部分肾切除术(PN)则存在争议。我们这项回顾性研究的目的是表明,在某些单侧WT病例中,保留肾手术可以成为肾切除术的合理替代方案,并讨论经肿瘤剜除术治疗的双侧WT患者的结果。

材料与方法

1981年至1998年,7例单侧肾母细胞瘤患者(4例I期、1例III期和2例IV期)接受了PN肿瘤切除术(5例右侧、2例左侧),当肿瘤体积在化疗4至6周后缩小至少50%、肿瘤位于一个肾极或易于切除、剩余50%或更多的肾组织且术中组织学检查显示腹主动脉旁淋巴结无转移时,计划进行PN手术。4例双侧WT患者(V期)接受了双侧肿瘤剜除术——除1例患者因肿瘤经下腔静脉延伸至右心房而不得不切除对侧肾脏。所有患者(n = 11)均接受了术前和术后化疗,4例患者还接受了放疗。

结果

所有单侧WT患者(n = 7)均存活且无疾病(随访时间:平均6.6年,范围:28个月至11年),肾功能正常,尽管2例接受二次肾切除术的患者肌酐清除率处于较低范围。6例患者成功进行了初次PN手术。1例III期肿瘤患者(腹膜内转移,淋巴结无转移),PN术后2天因肾动脉血栓形成而需要进行二次肾切除术。1例IV期肿瘤患者(肺转移,淋巴结无转移),初次切除距离肿瘤边缘不够远,因此不得不切除一片切缘无肿瘤的额外组织。该患者在PN术后19个月出现局部复发,此后不得不接受肾切除术。在双侧WT患者组(n = 4)中,1名儿童在术后化疗期间因中心静脉导管败血症于术后2个月死亡。1例患者还患有下腔静脉肿瘤血栓形成并延伸至右心房,因此需要切除右肾,术后4.7年出现慢性肾衰竭。另外2例V期肿瘤患者的肌酐清除率在正常范围内。

结论

保留肾手术仍然是双侧WT患者的首选手术方法,但当必须切除一侧肾脏时存在慢性肾衰竭的风险。对于单侧WT儿童患者,如果遵循严格的指导原则,如术前化疗对肿瘤反应良好且通过健康肾组织远离肿瘤边缘易于切除,由经验丰富的外科医生进行PN手术是肾切除术的合理替代方案。腹主动脉旁淋巴结必须无肿瘤侵犯,以避免局部放疗。PN可防止患者因异时性WT或随后的肾外伤导致对侧肾切除术后需要进行透析。

相似文献

1
Nephron-sparing procedures in 11 patients with Wilms' tumor.11例肾母细胞瘤患者的保肾手术
Pediatr Surg Int. 2003 Aug;19(6):457-62. doi: 10.1007/s00383-003-0957-x. Epub 2003 May 17.
2
Is partial nephrectomy appropriate treatment for unilateral Wilms' tumor?部分肾切除术是单侧肾母细胞瘤的合适治疗方法吗?
J Pediatr Surg. 1998 Feb;33(2):165-70. doi: 10.1016/s0022-3468(98)90425-0.
3
Management of bilateral Wilms tumor over three decades: The perspective of a single center.三十多年来双侧肾母细胞瘤的管理:单中心视角
J Pediatr Urol. 2015 Jun;11(3):118.e1-6. doi: 10.1016/j.jpurol.2014.11.012. Epub 2015 Jan 30.
4
Pathological review of Wilms tumor nephrectomy specimens and potential implications for nephron sparing surgery in Wilms tumor.威尔姆斯瘤肾切除术标本的病理检查与保肾手术治疗威尔姆斯瘤的潜在影响。
J Urol. 2012 Oct;188(4 Suppl):1506-10. doi: 10.1016/j.juro.2012.02.025. Epub 2012 Aug 19.
5
"Zero-Ischemia" Laparoscopic-assisted Partial Nephrectomy for the Management of Selected Children With Wilms Tumor Following Neoadjuvant Chemotherapy.“零缺血”腹腔镜辅助部分肾切除术用于新辅助化疗后特定肾母细胞瘤患儿的治疗
Urology. 2017 Feb;100:103-110. doi: 10.1016/j.urology.2016.08.051. Epub 2016 Oct 6.
6
Nephron-sparing partial nephrectomy for bilateral Wilms' tumor.保留肾单位的部分肾切除术治疗双侧肾母细胞瘤。
J Pediatr Surg. 2012 Jun;47(6):1234-8. doi: 10.1016/j.jpedsurg.2012.03.032.
7
Development of hypertension is less frequent after bilateral nephron sparing surgery for bilateral Wilms tumor in a long-term survey.在一项长期调查中,双侧保留肾单位手术治疗双侧 Wilms 肿瘤后高血压的发生频率较低。
J Urol. 2015 Jan;193(1):262-6. doi: 10.1016/j.juro.2014.07.116. Epub 2014 Aug 7.
8
Local control in synchronous bilateral Wilms tumor.同步双侧肾母细胞瘤的局部控制
Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):541-8. doi: 10.1016/s0360-3016(96)00377-x.
9
Bilateral Wilms' tumors: a single-center experience with 19 cases.双侧肾母细胞瘤:19例单中心经验
J Pediatr Surg. 2005 Aug;40(8):1289-94. doi: 10.1016/j.jpedsurg.2005.05.013.
10
Bilateral Wilms' tumor.双侧肾母细胞瘤。
Pediatr Surg Int. 1999;15(1):46-9. doi: 10.1007/s003830050510.

引用本文的文献

1
Surgery in Bilateral Wilms Tumor-A Single-Center Experience.双侧肾母细胞瘤的手术治疗——单中心经验
Children (Basel). 2023 Nov 7;10(11):1790. doi: 10.3390/children10111790.
2
Nephron-Sparing Surgery in Nonsyndromic Unilateral Wilms' tumor: An Insight into the Ongoing Surgical Controversy.非综合征性单侧肾母细胞瘤的保肾手术:对当前手术争议的洞察
J Indian Assoc Pediatr Surg. 2022 Jan-Feb;27(1):13-24. doi: 10.4103/jiaps.jiaps_205_21. Epub 2022 Jan 11.
3
Effectiveness of Nephron Sparing Surgery and Radical Nephrectomy in the Management of Unilateral Wilms Tumor: A Meta-Analysis.

本文引用的文献

1
Wilms tumor: does tumorectomy leave neoplastic tissue residual?肾母细胞瘤:肿瘤切除术会残留肿瘤组织吗?
Med Pediatr Oncol. 2000 Jun;34(6):429-31; discussion 432-3. doi: 10.1002/(sici)1096-911x(200006)34:6<429::aid-mpo9>3.0.co;2-d.
2
Surgical considerations for patients with Wilms' tumor.肾母细胞瘤患者的手术考量
Semin Urol Oncol. 1999 Feb;17(1):33-9.
3
Pediatric genitourinary tumors.小儿泌尿生殖系统肿瘤
保留肾单位手术与根治性肾切除术治疗单侧肾母细胞瘤的疗效:一项荟萃分析
Front Oncol. 2020 Sep 4;10:1248. doi: 10.3389/fonc.2020.01248. eCollection 2020.
4
Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysis.保留肾单位手术的应用及其对肾母细胞瘤患儿生存的影响:一项监测、流行病学和最终结果(SEER)分析
J Urol. 2014 Oct;192(4):1196-202. doi: 10.1016/j.juro.2014.04.003. Epub 2014 Apr 13.
5
Nephron sparing surgery for unilateral non-syndromic wilms tumor.保留肾单位手术治疗单侧非综合征性肾母细胞瘤。
Indian J Surg Oncol. 2014 Mar;5(1):11-6. doi: 10.1007/s13193-013-0284-1. Epub 2014 Jan 22.
6
Wilms tumor.肾母细胞瘤
Adv Pediatr. 2012;59(1):247-67. doi: 10.1016/j.yapd.2012.04.001.
7
Contemporary use of nephron-sparing surgery for children with malignant renal tumors at freestanding children's hospitals.独立儿童医院中儿童肾恶性肿瘤采用保留肾单位手术的当代应用。
Urology. 2011 Aug;78(2):422-6. doi: 10.1016/j.urology.2010.12.048.
8
Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.非 WT1 综合征型肾母细胞瘤发生终末期肾病的风险因素。
J Urol. 2011 Aug;186(2):378-86. doi: 10.1016/j.juro.2011.03.110. Epub 2011 Jun 17.
9
Management of Wilms' tumor: NWTS vs SIOP.肾母细胞瘤的管理:美国国立Wilms肿瘤研究组(NWTS)与国际小儿肿瘤学会(SIOP)的对比
J Indian Assoc Pediatr Surg. 2009 Jan;14(1):6-14. doi: 10.4103/0971-9261.54811.
10
Wilms' tumor.肾母细胞瘤
Curr Opin Pediatr. 2009 Jun;21(3):357-64. doi: 10.1097/MOP.0b013e32832b323a.
Curr Opin Oncol. 1998 May;10(3):253-60. doi: 10.1097/00001622-199805000-00013.
4
Current concepts in the biology and management of Wilms tumor.肾母细胞瘤生物学与管理的当前概念
J Urol. 1998 Apr;159(4):1316-25.
5
Is partial nephrectomy appropriate treatment for unilateral Wilms' tumor?部分肾切除术是单侧肾母细胞瘤的合适治疗方法吗?
J Pediatr Surg. 1998 Feb;33(2):165-70. doi: 10.1016/s0022-3468(98)90425-0.
6
[Wilms tumor treated with partial surgery. 31-year survival].[接受部分手术治疗的肾母细胞瘤。31年生存期]
Arch Esp Urol. 1997 Sep;50(7):756-9.
7
Nephroblastoma.肾母细胞瘤
Semin Pediatr Surg. 1997 Feb;6(1):11-6.
8
Enucleative surgery for stage I nephroblastoma with a normal contralateral kidney.对侧肾脏正常的I期肾母细胞瘤的剜除术。
J Urol. 1996 Nov;156(5):1788-91; discussion 1791-3.
9
Renal salvage procedures in patients with synchronous bilateral Wilms' tumors: a report from the National Wilms' Tumor Study Group.双侧同时性肾母细胞瘤患者的肾脏挽救手术:来自国家肾母细胞瘤研究组的报告
J Pediatr Surg. 1996 Aug;31(8):1020-5. doi: 10.1016/s0022-3468(96)90077-9.
10
Renal failure in Wilms' tumor patients: a report from the National Wilms' Tumor Study Group.肾母细胞瘤患者的肾衰竭:来自国家肾母细胞瘤研究组的报告。
Med Pediatr Oncol. 1996 Feb;26(2):75-80. doi: 10.1002/(SICI)1096-911X(199602)26:2<75::AID-MPO1>3.0.CO;2-R.